Chronic Pain: Types, Neuroscience, and a Complete Treatment Guide
Explore the clinic directoryIn this article
- What Makes Pain “Chronic”?
- How Common Is Chronic Pain in the United States?
- The Three Types of Chronic Pain
- Common Chronic Pain Conditions
- Pain Neuroscience: How Your Nervous System Creates Chronic Pain
- Diagnosis and Assessment
- Who Treats Chronic Pain?
- Conventional Treatments
- Interventional Approaches
- Regenerative Options for Structural Pain
- Integrative and Behavioral Approaches
- Chronic Pain and Mental Health
- Opioid Alternatives: Building a Modern Pain Plan
- Building a Multidisciplinary Pain Management Plan
- Which Chronic Pain Treatments Have the Strongest Evidence?
- What Does Chronic Pain Treatment Cost, and Does Insurance Cover It?
- How to Choose a Chronic Pain Clinic
- Related Reading
- Frequently Asked Questions
- Sources
Key Takeaways
- Chronic pain is pain that persists or recurs for more than 3 months, according to the International Association for the Study of Pain (IASP) classification used in ICD-11 (Treede et al., 2019), and it involves measurable changes in the nervous system, not just “acute pain that stuck around.”
- It is common: the CDC estimates that 20.9 percent of US adults, about 51.6 million people, had chronic pain in 2021, and 6.9 percent had high-impact chronic pain that limited daily life (Rikard et al., 2023).
- Three main types: nociceptive pain (tissue damage), neuropathic pain (nerve damage or disease), and nociplastic pain (central sensitization with no clear tissue or nerve injury), a category described by Kosek and colleagues in 2016.
- Common conditions include fibromyalgia, chronic low back pain, complex regional pain syndrome (CRPS), peripheral neuropathy, chronic migraine, and tension-type headache.
- Treatment has shifted away from opioid-centered care: the 2022 CDC opioid prescribing guideline favors non-opioid and non-drug options first, and NICE guideline NG193 (2021) recommends exercise, psychological therapy, and acupuncture for chronic primary pain.
- Pain neuroscience education, exercise, and psychological therapies such as CBT and ACT have the strongest evidence and are often underused, while regenerative injections like PRP and stem cell therapy remain mostly off label and cash pay.
Chronic pain is pain that persists or recurs for more than three months, and it changes how the nerves, spinal cord, and brain process pain signals, according to the IASP classification adopted in ICD-11 [1]. About 20.9 percent of US adults, roughly 51.6 million people, lived with chronic pain in 2021, according to the CDC [23], and the best supported treatment plans combine exercise, psychological therapy, and medications matched to the pain type: nociceptive, neuropathic, or nociplastic.
What this article covers
If you have lived with pain for months or years, you already know that chronic pain is not just a physical sensation. It changes how you sleep, how you think, how you relate to your body, and how you move through daily life. You may have been told the pain is “in your head” or that imaging does not explain your symptoms. Neither of those statements helps, and both miss the point.
Chronic pain is a real, measurable neurobiological condition. It involves changes in how your nervous system processes signals, and those changes can persist long after the original injury has healed. Understanding what is actually happening in your body is the first step toward effective treatment.
The sections below cover the science behind chronic pain, the major conditions it includes, how it is diagnosed, who treats it, and the full range of treatment options available today, from medications and interventional procedures to regenerative therapies and integrative approaches. A comparison table, a cost and insurance section, and a checklist for choosing a pain clinic come near the end.
What Makes Pain “Chronic”?
Acute pain is a warning signal. You touch a hot pan, your hand hurts, you pull it away. The pain has a clear cause, a protective purpose, and a predictable timeline. It resolves as the tissue heals.
Chronic pain is different. The International Association for the Study of Pain defines it as pain persisting or recurring for more than three months [1]. But the distinction is not just about duration. Chronic pain involves real changes in how your peripheral nerves, spinal cord, and brain process pain signals.
In many cases, the nervous system becomes sensitized. Neurons that transmit pain signals become hyperexcitable, firing more easily and more often. Pain pathways that should quiet down after healing instead stay active or even amplify. This is not imaginary. It shows up on functional MRI scans and in measurable changes to nerve conduction, neurotransmitter levels, and brain structure [2].
This means that chronic pain can persist even when there is no ongoing tissue damage. The alarm system itself has malfunctioned.
Chronic primary and chronic secondary pain
The ICD-11 classification developed by the IASP task force splits chronic pain into two groups [1]. Chronic primary pain is pain that is a condition in its own right, such as fibromyalgia or nonspecific chronic low back pain. Chronic secondary pain is pain that follows from another disease, such as osteoarthritis, cancer, surgery, or nerve injury.
The distinction matters for treatment. NICE guideline NG193 (2021), from the UK National Institute for Health and Care Excellence, gives specific recommendations for chronic primary pain, including supervised exercise, psychological therapy, and acupuncture, and advises against starting opioids, NSAIDs, gabapentinoids, or paracetamol for it [24].
How Common Is Chronic Pain in the United States?
Chronic pain affected an estimated 20.9 percent of US adults, about 51.6 million people, in 2021, according to a CDC analysis of the National Health Interview Survey by Rikard and colleagues published in MMWR in 2023 (Rikard et al., 2023) [23]. The same analysis found that 6.9 percent of adults, about 17.1 million people, had high-impact chronic pain, meaning pain that substantially restricts work, social, or self-care activities.
The CDC report links chronic pain with depression, dementia, higher suicide risk, and substance use, and it found higher prevalence among American Indian and Alaska Native adults, bisexual adults, and adults who are divorced or separated [23]. Low back pain alone is the leading cause of years lived with disability worldwide, according to the Global Burden of Disease study [6].
The Three Types of Chronic Pain
Clinicians sort chronic pain into three mechanistic types: nociceptive, neuropathic, and nociplastic. Many patients have more than one at the same time, which is called mixed pain. Naming the type matters because each one responds to different treatments.
Nociceptive Pain
This is pain caused by actual or threatened damage to non-neural tissue. Your nociceptors (pain-sensing nerve endings in skin, muscles, joints, and organs) detect mechanical, thermal, or chemical stimuli and send signals up to your brain. Osteoarthritis, inflammatory conditions, and many forms of musculoskeletal pain fall into this category.
Nociceptive pain generally correlates with identifiable tissue pathology. It tends to respond to anti-inflammatory medications, physical therapy, and structural interventions.
Neuropathic Pain
Neuropathic pain results from damage or disease affecting the somatosensory nervous system. The nerves themselves are injured or dysfunctional. Common examples include diabetic neuropathy, postherpetic neuralgia (pain after shingles), trigeminal neuralgia, and radiculopathy from a herniated disc compressing a nerve root [3].
Patients often describe neuropathic pain as burning, shooting, electric, or tingling. It can include allodynia (pain from stimuli that should not hurt, like a light touch) and hyperalgesia (exaggerated pain from mildly painful stimuli). Neuropathic pain tends to respond poorly to standard painkillers like NSAIDs and often requires medications that target nerve signaling, such as gabapentinoids or certain antidepressants. Our dedicated overview of neuropathic pain treatment options goes deeper on nerve pain medications and procedures.
Nociplastic Pain (Central Sensitization)
This is the most recently recognized category, and it is arguably the most misunderstood. Nociplastic pain arises from altered nociception, meaning the pain processing system itself is dysfunctional, without clear evidence of tissue damage or nerve injury [4].
Fibromyalgia is the most well-known nociplastic condition. The brain and spinal cord amplify pain signals, lower pain thresholds, and create widespread pain sensitivity. Imaging studies show altered connectivity in pain-processing brain regions and changes in descending pain inhibition pathways [5].
Nociplastic pain is not “just psychological,” but psychological factors like stress, trauma history, and catastrophizing can influence the degree of central sensitization. This is why treatment for nociplastic pain often includes psychological and neuroscience-based approaches alongside physical treatments.
How do the three pain types compare?
The table below summarizes the three chronic pain types using the mechanisms, descriptions, and first-line approaches covered in this section and in the treatment sections that follow.
| Pain type | What drives it | How it often feels | Typical examples | Approaches that usually come first |
|---|---|---|---|---|
| Nociceptive | Actual or threatened damage to tissue such as joints, tendons, muscle, or organs | Aching, throbbing, worse with load or movement | Osteoarthritis, tendinopathy, inflammatory arthritis | Exercise and physical therapy, NSAIDs or topical NSAIDs, injections for a clear structural source |
| Neuropathic | Damage or disease of the somatosensory nerves | Burning, shooting, electric, tingling, numb | Diabetic neuropathy, postherpetic neuralgia, sciatica from a disc | Gabapentinoids, SNRIs or tricyclics, topical lidocaine or capsaicin, nerve-targeted procedures |
| Nociplastic | Altered pain processing in the brain and spinal cord (central sensitization) | Widespread, fluctuating, with fatigue, poor sleep, and sensitivity to touch | Fibromyalgia, irritable bowel syndrome, chronic tension-type headache | Pain neuroscience education, graded exercise, CBT or ACT, sleep care, SNRIs or low-dose tricyclics |
Common Chronic Pain Conditions
Fibromyalgia
Fibromyalgia affects an estimated 2 to 4 percent of the population and is characterized by widespread musculoskeletal pain, fatigue, sleep disturbance, and cognitive difficulties (“fibro fog”). It is a prototypical central sensitization condition. Diagnosis is clinical, based on symptom criteria rather than lab tests or imaging [5].
Treatment typically combines medication (duloxetine, milnacipran, pregabalin), aerobic exercise, sleep optimization, and cognitive behavioral therapy. Many patients also benefit from pain neuroscience education and graded exercise programs. The fibromyalgia condition page and the fibromyalgia treatment guide cover diagnosis criteria and treatment options in more detail.
Chronic Low Back Pain
Low back pain is the leading cause of disability worldwide [6]. While acute back pain usually resolves within weeks, about 20 percent of cases become chronic. The relationship between imaging findings and pain is often weak. Many people with herniated discs on MRI have no pain, while many people with severe back pain have unremarkable imaging.
This disconnect points to the role of central sensitization, deconditioning, fear-avoidance behavior, and psychosocial factors in chronic back pain. Evidence strongly supports exercise, physical therapy, and psychological approaches over passive treatments or surgery for most cases of nonspecific chronic low back pain [7]. Options specific to the spine, from physical therapy to injections, are compared in the low back pain treatment guide.
Complex Regional Pain Syndrome (CRPS)
CRPS typically develops after an injury (often to a limb) and involves pain that is disproportionate to the original trauma, along with swelling, skin color and temperature changes, and motor dysfunction. It involves both peripheral and central sensitization and can be extremely disabling. Early aggressive treatment with physical therapy, nerve blocks, and sometimes ketamine or spinal cord stimulation offers the best outcomes [8]. The Budapest criteria, described in the Harden guidelines, are the standard clinical tool for diagnosing CRPS, and the CRPS treatment guide walks through the options.
Peripheral Neuropathy
Damage to peripheral nerves from diabetes, chemotherapy, alcohol use, autoimmune conditions, or other causes can produce chronic burning, tingling, numbness, and pain, most commonly in the hands and feet. Management focuses on treating the underlying cause when possible, controlling symptoms with medications like gabapentin, pregabalin, or duloxetine, and preventing further nerve damage [3].
Chronic Headache Disorders
Migraine and tension-type headaches become chronic when they occur 15 or more days per month. Chronic migraine affects about 2 percent of the general population and involves central sensitization of trigeminal pathways. Treatment includes preventive medications (beta-blockers, topiramate, CGRP monoclonal antibodies), acute medications, lifestyle modifications, and neuromodulation devices [9]. Readers with frequent attacks can compare preventive options in the migraine treatment guide.
Joint pain and osteoarthritis
Osteoarthritis of the knee, hip, and hand is one of the most common sources of chronic nociceptive pain, especially after middle age. Pain comes from cartilage loss, bone changes, and inflammation of the joint lining, but pain intensity does not track neatly with X-ray severity, so central sensitization can add to it over time. Exercise, weight management, topical or oral NSAIDs, and injections are the usual tools, and the joint pain condition page covers causes beyond arthritis.
Pain Neuroscience: How Your Nervous System Creates Chronic Pain
Chronic pain is produced by changes at three levels of the nervous system: the nerve endings in tissue (peripheral sensitization), the spinal cord (central sensitization), and the brain (neuroplasticity). Each level can keep pain going after tissue has healed, which is why treatments that work on the nervous system often help when treatments aimed only at tissue do not.
Peripheral Sensitization
After tissue injury, inflammatory mediators (prostaglandins, bradykinin, cytokines) lower the activation threshold of nociceptors at the injury site. This is why an injured area becomes more sensitive to touch and pressure. In acute pain, this resolves as inflammation subsides. In chronic pain, peripheral sensitization can persist due to ongoing low-grade inflammation or nerve damage.
Central Sensitization
Central sensitization is the amplification of neural signaling within the central nervous system that causes pain hypersensitivity. Neurons in the dorsal horn of the spinal cord become hyperexcitable. NMDA receptors are upregulated. Descending inhibitory pathways from the brainstem (which normally dampen pain signals) become less effective [2].
The result is that normal sensory input gets interpreted as painful (allodynia), mildly painful input becomes severely painful (hyperalgesia), and pain spreads beyond the original injury site. Central sensitization is a key mechanism in fibromyalgia, chronic tension-type headache, irritable bowel syndrome, and many other chronic pain conditions. Clifford Woolf at Harvard Medical School, whose 2011 review in Pain is the standard reference on the topic, frames it as pain driven by changes in the central nervous system rather than by ongoing input from injured tissue [2].
Neuroplasticity and Pain
The brain physically reorganizes in response to chronic pain. Functional MRI studies show altered activation patterns, changes in gray matter volume, and disrupted connectivity in regions involved in pain processing, emotional regulation, and cognition [10]. The good news is that neuroplasticity works both ways. Effective treatment can reverse some of these brain changes, which is part of why multidisciplinary pain programs that combine physical, psychological, and educational approaches show lasting benefits.
Pain Catastrophizing
Pain catastrophizing is a cognitive pattern characterized by rumination about pain, magnification of pain-related threats, and helplessness. It is one of the strongest psychological predictors of chronic pain outcomes, more predictive than tissue pathology in many studies [11]. This is not about blaming the patient. Catastrophizing is a measurable cognitive process that amplifies central sensitization. Interventions like cognitive behavioral therapy directly target it and produce measurable reductions in both catastrophizing and pain intensity.
Diagnosis and Assessment
Diagnosing chronic pain involves more than identifying a structural cause. A thorough assessment includes:
- Pain history: location, duration, quality (aching, burning, sharp, shooting), aggravating and relieving factors, temporal pattern
- Functional impact: how pain affects sleep, work, movement, mood, and daily activities
- Psychological screening: depression, anxiety, catastrophizing, trauma history, sleep quality
- Physical examination: neurological testing, range of motion, provocative tests, assessment of central sensitization signs (allodynia, widespread hyperalgesia)
- Imaging and labs: MRI, X-ray, nerve conduction studies, blood work as appropriate, keeping in mind that imaging findings often do not correlate with pain severity
- Validated pain scales: numeric rating scale, Brief Pain Inventory, Central Sensitization Inventory, Pain Catastrophizing Scale
The goal is to classify the pain mechanism (nociceptive, neuropathic, nociplastic, or mixed), identify treatable contributing factors, and build a treatment plan that addresses all dimensions of the pain experience.
When is pain a reason to see a doctor quickly?
Some symptoms alongside pain point to a problem that needs prompt medical assessment rather than a chronic pain plan. These include new weakness or numbness in a limb, loss of bladder or bowel control, fever or unexplained weight loss with back pain, pain after a significant fall or accident, and a sudden severe headache unlike previous ones. A primary care physician or emergency department rules these out before chronic pain care begins.
Who Treats Chronic Pain?
Chronic pain is treated by a team rather than a single specialty. Pain medicine physicians lead most interventional care; in the United States they usually complete residency in anesthesiology, physical medicine and rehabilitation (PM&R), or neurology, followed by a pain medicine fellowship and subspecialty board certification. Primary care physicians coordinate long-term care and prescribing.
Other clinicians on a typical pain team include:
- Physical therapists, who run graded exercise, graded exposure, and manual therapy programs.
- Pain psychologists, who deliver CBT, ACT, pain reprocessing approaches, and biofeedback.
- Rheumatologists, for inflammatory arthritis, lupus, and fibromyalgia diagnosis.
- Neurologists, for neuropathy, chronic migraine, and nerve conduction testing.
- Orthopedic and sports medicine physicians, for joint and tendon pain, including regenerative injections such as PRP.
- Licensed acupuncturists, chiropractors, and integrative or functional medicine physicians, who often provide complementary care alongside the core team.
Interdisciplinary pain rehabilitation programs, where these clinicians work from one shared plan, have the strongest evidence for chronic low back pain, according to a Cochrane-based review by Kamper and colleagues in the BMJ (2015) [22].
Conventional Treatments
Conventional chronic pain treatment matches the medication to the pain mechanism: NSAIDs for inflammatory nociceptive pain, gabapentinoids and SNRIs for neuropathic pain, and SNRIs or low-dose tricyclics for nociplastic pain. Topical options such as lidocaine patches, capsaicin, and diclofenac gel are useful for localized pain with fewer whole-body side effects.
Non-Opioid Medications
NSAIDs (ibuprofen, naproxen, celecoxib) reduce inflammation and are most effective for nociceptive pain with an inflammatory component. Long-term use carries risks of GI bleeding, cardiovascular events, and kidney damage. They are generally first-line for conditions like osteoarthritis and inflammatory musculoskeletal pain [12].
Acetaminophen provides mild analgesic effects with a better GI safety profile than NSAIDs but limited anti-inflammatory activity. Its efficacy for chronic pain conditions like low back pain has been questioned by recent evidence [7].
Antidepressants for pain: SNRIs (duloxetine, venlafaxine) and tricyclic antidepressants (amitriptyline, nortriptyline) modulate descending pain inhibition pathways and are effective for neuropathic pain, fibromyalgia, and chronic headache. Their pain-relieving effect is independent of their antidepressant action and occurs at lower doses [3]. NICE guideline NG193 also lists amitriptyline, citalopram, duloxetine, fluoxetine, paroxetine, and sertraline as options to consider for chronic primary pain, even without depression [24].
Gabapentinoids (gabapentin, pregabalin) bind to calcium channels in the nervous system and reduce excitatory neurotransmitter release. They are first-line for neuropathic pain and approved for fibromyalgia (pregabalin). Side effects include drowsiness, dizziness, and weight gain. There is also growing concern about misuse potential [3].
Opioids: The Shift Away
Opioids were widely prescribed for chronic pain through the late 1990s and 2000s. The consequences of that prescribing pattern are well documented: addiction, overdose deaths, hyperalgesia (opioids paradoxically increasing pain sensitivity with long-term use), and modest long-term efficacy at best [13].
Current guidelines from the CDC, VA/DoD, and major pain societies recommend opioids only when non-opioid therapies have been tried and failed, at the lowest effective dose, with regular reassessment, and with clear functional goals. For most chronic non-cancer pain, the risks of long-term opioid therapy outweigh the benefits [13]. The 2022 CDC clinical practice guideline by Dowell and colleagues (CDC opioid prescribing guideline, 2022) states that nonopioid therapies are preferred for subacute and chronic pain.
This does not mean opioids are never appropriate. Some patients with severe chronic pain do benefit from carefully managed opioid therapy. But the emphasis has shifted toward multimodal approaches that address pain through multiple mechanisms rather than relying on a single drug class. Anyone already taking long-term opioids should change the dose only with their prescriber, because abrupt tapering carries its own risks, a point the 2022 CDC guideline makes directly. Our article on managing chronic pain without opioids covers the alternatives in practical terms.
Interventional Approaches
Interventional pain procedures target a specific pain generator, such as a facet joint, a nerve root, or the spinal cord, with injections, heat, or electrical stimulation. They are performed by pain medicine physicians, usually under fluoroscopic or ultrasound guidance, and they work best when a diagnostic block has confirmed where the pain comes from.
Nerve Blocks
Nerve blocks involve injecting local anesthetic (sometimes with corticosteroid) near specific nerves or nerve clusters. They serve both diagnostic and therapeutic purposes. If blocking a specific nerve eliminates the pain, that confirms the pain source. Epidural steroid injections, facet joint blocks, and peripheral nerve blocks are among the most common. Effects are typically temporary (weeks to months) but can be repeated [14].
Radiofrequency Ablation (RFA)
RFA uses heat generated by radio waves to create a lesion on a nerve, disrupting its ability to transmit pain signals. It is most commonly used for facet joint pain in the spine and sacroiliac joint pain. Pain relief typically lasts 6 to 12 months before the nerve regenerates. Cooled radiofrequency and pulsed radiofrequency are variations that may offer advantages for certain pain types [14]. Readers with pain low in the back and buttock can read more on the sacroiliac joint pain condition page.
Spinal Cord Stimulation (SCS)
SCS involves implanting electrodes along the spinal cord that deliver electrical pulses to modulate pain signaling. It is FDA-approved for chronic neuropathic pain, failed back surgery syndrome, and CRPS. Newer high-frequency (10 kHz) and burst stimulation patterns have improved outcomes compared to older tonic stimulation [8]. Patients typically undergo a trial period before permanent implantation.
Ketamine Infusions
Ketamine is an NMDA receptor antagonist that can “reset” central sensitization. Subanesthetic IV ketamine infusions (typically 0.5 mg/kg over 40 minutes, or longer infusions over several hours) have shown benefit for CRPS, fibromyalgia, neuropathic pain, and treatment-resistant depression that accompanies chronic pain. The FDA has approved esketamine (nasal spray) for treatment-resistant depression, but IV ketamine for chronic pain remains off-label [15].
A 2019 meta-analysis of randomized trials by Orhurhu, Cohen, and colleagues in Anesthesia & Analgesia pooled 7 small trials with 211 patients and found a small reduction in pain scores, about 1.8 points on a 0 to 10 scale, lasting up to 2 weeks after the infusion; most included trials carried a high risk of bias [15]. Infusions for pain are usually cash pay. The ketamine therapy treatment guide explains protocols and side effects, and the national list of ketamine therapy clinics shows providers by state.
Transcranial Magnetic Stimulation (TMS)
Repetitive TMS applies magnetic pulses to specific brain regions to modulate neural activity. When targeted to the motor cortex or dorsolateral prefrontal cortex, it can reduce chronic pain through top-down modulation of pain processing circuits. Evidence is strongest for neuropathic pain and fibromyalgia, though response varies [16]. TMS is FDA cleared for depression, migraine, and OCD, but its use for chronic pain is off label; the TMS treatment guide covers the cleared indications.
Regenerative Options for Structural Pain
When chronic pain has a clear structural component (damaged tendons, ligaments, cartilage, or joints), regenerative medicine approaches aim to promote tissue repair rather than just blocking pain signals.
Regulation matters here. The FDA states that regenerative medicine therapies, including stem cell, exosome, and umbilical cord products, have not been approved to treat chronic pain or any orthopedic condition such as osteoarthritis, back pain, or tendonitis (FDA consumer information on regenerative medicine therapies) [25]. PRP and prolotherapy are offered off label, and all three are usually paid out of pocket.
Platelet-Rich Plasma (PRP)
PRP concentrates growth factors from your own blood and injects them into damaged tissue. Evidence is strongest for knee osteoarthritis, lateral epicondylitis (tennis elbow), and plantar fasciitis. For knee OA, a 2017 meta-analysis of 10 randomized trials with 1,069 patients by Dai and colleagues in Arthroscopy found PRP provided greater pain relief than hyaluronic acid at 12 months and greater relief than saline at 6 and 12 months (Dai et al., 2017) [17].
Preparation methods, platelet concentration, and the number of injections differ widely between clinics, which makes studies hard to compare. The PRP treatment guide explains how PRP is prepared, and the PRP clinic directory lists providers across the United States.
Mesenchymal Stem Cell Therapy
Stem cell injections (typically using mesenchymal stem cells from bone marrow or adipose tissue) are being investigated for joint degeneration, disc disease, and tendon injuries. Early clinical data is promising for knee osteoarthritis, but large randomized trials are still needed. This field is evolving rapidly, and patients should be cautious of clinics making claims that outpace the evidence [17]. The stem cell therapy guide explains the difference between FDA-regulated trials and cash-pay clinic offerings.
Prolotherapy
Prolotherapy involves injecting a dextrose (sugar water) solution into damaged ligaments or tendons to trigger a localized inflammatory response that stimulates repair. It has the longest track record of the regenerative injectables and moderate evidence supporting its use for chronic low back pain, knee osteoarthritis, and lateral epicondylitis [17]. A 2013 randomized trial by Rabago and colleagues at the University of Wisconsin, published in the Annals of Family Medicine, found that, at 52 weeks, dextrose prolotherapy improved knee osteoarthritis pain and function scores more than saline injections or at-home exercise [26]. The prolotherapy treatment guide covers how sessions work.
Regenerative therapies are most appropriate when there is identifiable structural pathology contributing to pain. They are not a substitute for addressing central sensitization, movement patterns, and psychological factors in patients with nociplastic or mixed pain presentations.
Integrative and Behavioral Approaches
Integrative and behavioral treatments change how the nervous system processes pain, and several of them have stronger evidence than most medications for long-term chronic pain. Pain neuroscience education, graded activity, cognitive behavioral therapy (CBT), acceptance and commitment therapy (ACT), mindfulness, acupuncture, and exercise are the core options, and they work best in combination.
Pain Neuroscience Education (PNE)
PNE teaches patients about the neurobiology of pain, including how the nervous system becomes sensitized, why pain does not always equal tissue damage, and how the brain constructs the pain experience. Multiple randomized trials show that PNE reduces pain catastrophizing, fear of movement, and disability, and improves outcomes when combined with exercise and manual therapy [18].
Understanding that your pain is real but that it reflects nervous system sensitization rather than ongoing tissue destruction can fundamentally change how you relate to pain and how you approach rehabilitation.
Graded Exposure and Graded Activity
Many people with chronic pain develop fear-avoidance behavior: they stop moving because they fear that activity will cause more damage. This leads to deconditioning, which increases pain sensitivity and disability in a vicious cycle.
Graded exposure gradually reintroduces feared movements and activities in a safe, structured way. Graded activity systematically increases physical activity levels based on time-based rather than pain-based pacing. Both approaches have strong evidence for chronic low back pain and other musculoskeletal pain conditions [18].
Cognitive Behavioral Therapy (CBT) for Pain
CBT for chronic pain targets the thoughts, beliefs, and behaviors that amplify pain and disability. It addresses catastrophizing, helplessness, fear-avoidance, and maladaptive coping strategies. CBT is one of the most well-studied psychological interventions for chronic pain, with consistent evidence showing reductions in pain intensity, disability, and psychological distress [11]. The 2020 Cochrane review by Williams and colleagues, drew on 59 CBT trials and found small benefits for pain, disability, and distress compared with usual care, and very small benefits compared with other active treatments [11].
Acceptance and Commitment Therapy (ACT)
ACT takes a different approach from CBT. Rather than trying to change pain-related thoughts, ACT focuses on accepting pain as part of present experience while committing to actions aligned with personal values. It emphasizes psychological flexibility: being willing to experience pain without letting it dictate behavior. ACT has growing evidence for chronic pain, particularly for improving function and quality of life, though the 2020 Cochrane review rated the ACT trials so far as moderate to very low quality [11].
Biofeedback
Biofeedback uses real-time monitoring of physiological signals (muscle tension, heart rate variability, skin conductance, brain waves) to help patients learn to regulate these processes. It is especially useful for tension-type headaches, TMJ pain, and conditions with a significant muscle tension component. Neurofeedback, a form of biofeedback targeting brainwave patterns, is being investigated for broader chronic pain applications. The biofeedback therapy guide explains how sessions run, and our article on biofeedback for chronic pain reviews the pain-specific research.
Acupuncture
Acupuncture involves inserting thin needles at specific points on the body. A 2018 individual patient data meta-analysis in the Journal of Pain (Vickers et al.) found that acupuncture was superior to sham acupuncture and no-acupuncture controls for chronic musculoskeletal pain, headache, and osteoarthritis, with effects persisting at 12 months [19]. It appears to work through multiple mechanisms including endorphin release, modulation of inflammatory mediators, and effects on connective tissue. NICE guideline NG193 suggests considering a single course of acupuncture for chronic primary pain [24].
Meditation and Mindfulness-Based Stress Reduction (MBSR)
MBSR, developed by Jon Kabat-Zinn specifically for chronic pain patients, is an 8-week program combining mindfulness meditation, body scanning, and gentle yoga. Research shows it reduces pain intensity, improves function, and decreases psychological distress. Neuroimaging studies demonstrate that mindfulness practice alters activity in pain-processing brain regions and strengthens prefrontal cortical control over pain perception [20].
In a 2016 randomized trial of 342 adults with chronic low back pain, published in JAMA by Cherkin and colleagues, 60.5 percent of the MBSR group and 57.7 percent of the CBT group had clinically meaningful improvement in function at 26 weeks, compared with 44.1 percent with usual care (Cherkin et al., 2016) [20]. The MBSR benefits persisted with little change at 52 weeks.
Exercise
Exercise is the single most broadly supported intervention for chronic pain across conditions. Aerobic exercise, resistance training, yoga, tai chi, aquatic therapy, and walking programs all show benefit. Exercise reduces central sensitization, improves mood, restores function, and triggers endogenous opioid and endocannabinoid release [7].
The key is starting at a level you can tolerate and progressing gradually. Exercise should be guided by time and function goals, not by pain levels. Some increase in pain during the early stages of an exercise program is normal and does not indicate harm. NICE guideline NG193 recommends a supervised group exercise program for adults with chronic primary pain [24].
Chronic Pain and Mental Health
Chronic pain and mental health conditions share neurobiology. The brain regions involved in processing pain overlap significantly with those involved in mood regulation, and the neurotransmitters involved (serotonin, norepinephrine, dopamine) are the same ones targeted by antidepressants.
Depression occurs in 30 to 50 percent of chronic pain patients. Anxiety is similarly common. Sleep disturbance affects the majority. These are not separate problems. Depression amplifies pain perception, poor sleep lowers pain thresholds, and anxiety drives hypervigilance and catastrophizing [11].
Effective chronic pain treatment must address mental health directly. This means screening for depression and anxiety, offering evidence-based psychological treatments, optimizing sleep, and integrating behavioral health into the pain management plan rather than treating pain and mental health in separate silos. The depression treatment guide and the insomnia treatment guide cover the two problems that most often travel with chronic pain.
Opioid Alternatives: Building a Modern Pain Plan
The move away from opioid-centered treatment has created space for more effective multimodal approaches. Evidence-supported opioid alternatives include:
- Non-opioid medications: NSAIDs, duloxetine, gabapentinoids, low-dose naltrexone (LDN), topical analgesics (lidocaine patches, capsaicin, diclofenac gel)
- Interventional procedures: nerve blocks, RFA, SCS, ketamine infusions
- Physical rehabilitation: physical therapy, exercise programs, aquatic therapy
- Psychological therapies: CBT, ACT, biofeedback, MBSR
- Regenerative medicine: PRP, prolotherapy for appropriate structural conditions
- Complementary approaches: acupuncture, yoga, tai chi
- Neuromodulation: TMS, transcutaneous electrical nerve stimulation (TENS)
Low-dose naltrexone (LDN) deserves special mention. At doses of 1 to 5 mg (far below the 50 mg dose used for addiction), naltrexone appears to reduce neuroinflammation and glial cell activation. Small trials show promise for fibromyalgia, CRPS, and other central sensitization conditions, though large-scale trials are still needed [21]. LDN for pain is off label and is usually prescribed through a compounding pharmacy; Jarred Younger and colleagues at Stanford ran several of the early fibromyalgia studies [21].
Other options sometimes offered for chronic pain have thinner evidence. Low-level laser therapy, also called photobiomodulation or cold laser, and red light therapy are being studied for joint and tendon pain, and the low-level laser therapy guide describes what the trials show so far. Extracorporeal shockwave therapy (ESWT) has better support for plantar fasciitis and some tendinopathies than for widespread pain.
Building a Multidisciplinary Pain Management Plan
The most effective approach to chronic pain is not any single treatment. It is a coordinated, multidisciplinary plan that addresses the biological, psychological, and social dimensions of pain.
A strong pain management plan typically includes:
- Accurate pain classification: Determine whether pain is primarily nociceptive, neuropathic, nociplastic, or mixed. This guides treatment selection.
- Education: Understand your pain neuroscience. Know that chronic pain reflects nervous system changes, not necessarily ongoing damage.
- Movement: Start a structured exercise program. This is non-negotiable for almost every chronic pain patient. Work with a physical therapist who understands pain science.
- Psychological support: Engage with CBT, ACT, or another evidence-based psychological approach. Address catastrophizing, fear-avoidance, depression, and sleep.
- Medications (targeted): Use non-opioid medications matched to your pain mechanism. SNRIs for nociplastic or neuropathic pain, NSAIDs for inflammatory nociceptive pain, gabapentinoids for neuropathic pain.
- Interventional procedures (when indicated): Nerve blocks, RFA, or neuromodulation for specific, identifiable pain generators.
- Regenerative therapies (when appropriate): PRP or prolotherapy for structural problems contributing to pain.
- Integrative therapies: Acupuncture, mindfulness, or biofeedback as adjuncts based on your preferences and response.
- Self-management: Develop pacing strategies, stress management practices, and a long-term plan you can sustain independently.
The team may include a pain medicine physician, physical therapist, psychologist, and primary care provider. Communication between providers is critical. The best outcomes come from interdisciplinary pain rehabilitation programs where these providers work together rather than in isolation [22].
Chronic pain treatment is not about eliminating pain entirely. For many patients, that is not a realistic goal. It is about reducing pain to manageable levels, restoring function, improving quality of life, and building skills to manage flare-ups when they occur. The chronic pain treatment guide summarizes these options side by side, and the chronic pain condition page links to related conditions.
Which Chronic Pain Treatments Have the Strongest Evidence?
Exercise, psychological therapies such as CBT and MBSR, pain neuroscience education, and interdisciplinary rehabilitation have the broadest evidence across chronic pain conditions. Medications and procedures help when they are matched to a specific pain mechanism or pain generator. Regenerative injections have the narrowest evidence and are mostly limited to joint and tendon pain. The table pulls together the findings cited in the sections above.
| Treatment | Best supported uses | Key evidence cited above | Regulatory and coverage status |
|---|---|---|---|
| Exercise and physical therapy | Low back pain, osteoarthritis, fibromyalgia, most chronic pain | Foster et al., Lancet 2018; NICE NG193 (2021) | Standard care, commonly covered by insurance |
| CBT, ACT, and MBSR | Chronic pain across conditions, especially low back pain | Williams et al., Cochrane 2020; Cherkin et al., JAMA 2016 | Standard care, coverage varies by plan |
| Interdisciplinary rehabilitation | Chronic low back pain with high disability | Kamper et al., BMJ 2015 | Offered by hospital and academic pain programs |
| Acupuncture | Musculoskeletal pain, headache, osteoarthritis | Vickers et al., J Pain 2018 | Coverage varies; Medicare covers it for chronic low back pain |
| SNRIs, tricyclics, gabapentinoids | Neuropathic pain, fibromyalgia | Finnerup et al., Lancet Neurol 2015 | FDA approved for specific pain conditions |
| Nerve blocks and RFA | Facet joint and sacroiliac joint pain | Cohen et al., Lancet 2021 | Commonly covered when criteria are met |
| Spinal cord stimulation | Neuropathic pain, failed back surgery syndrome, CRPS | Harden et al., Pain Med 2022 | FDA approved devices; trial period first |
| Ketamine infusions | CRPS, refractory neuropathic and mixed pain | Orhurhu et al., Anesth Analg 2019 | Off label for pain, usually cash pay |
| PRP and prolotherapy | Knee osteoarthritis, tennis elbow, plantar fasciitis | Dai et al., Arthroscopy 2017; Rabago et al., Ann Fam Med 2013 | Off label, usually cash pay |
| Stem cell therapy | Investigational for joint and disc disease | Large randomized trials still needed | Not FDA approved for any orthopedic or pain condition |
What Does Chronic Pain Treatment Cost, and Does Insurance Cover It?
Insurance coverage for chronic pain treatment depends on whether the treatment is standard care or off label. Physical therapy, generic pain medications, psychological therapy, nerve blocks, radiofrequency ablation, and spinal cord stimulation are commonly covered by Medicare, Medicaid, and private plans when medical criteria and prior authorization rules are met. Medicare has covered acupuncture for chronic low back pain since 2020.
Ketamine infusions for pain, PRP, prolotherapy, stem cell injections, and most low-level laser treatments are usually paid out of pocket because they are off label or considered investigational by insurers. Prices vary widely by clinic, region, and the number of sessions a protocol uses. Ask any clinic for a written quote that lists every session, follow-up visit, and product cost before starting, and ask whether a health savings account (HSA) or flexible spending account (FSA) can be used.
How to Choose a Chronic Pain Clinic
A well run chronic pain clinic starts with a full assessment, explains which pain type it thinks you have, and offers more than one kind of treatment. Clinics that lead with a single cash-pay procedure for every patient deserve more questions, especially for regenerative injections the FDA has not approved for pain.
Questions worth asking before booking:
- Who will treat me, and what board certification do they hold in pain medicine, anesthesiology, PM&R, or neurology?
- Which pain type do you think I have, and why does this treatment fit it?
- What does the published evidence show for this treatment in my condition, and is it on label or off label?
- How will we measure whether it is working, and when would we stop?
- Do you coordinate with physical therapy and pain psychology, or refer out for them?
- What is the full cost, and which parts will my insurance cover?
Regenerated.com lists clinics by treatment and location, and it is free for patients to use. Listing order is not paid ranking. Featured slots are labeled and capped, and Verified means a clinic completed credential checks, not that it paid more. Inclusion in the directory is not an endorsement, and the guide to featured, verified, and organic listings explains each label. You can browse biofeedback therapy clinics, clinics offering platelet-rich plasma injections, or ketamine infusion providers by state.
Related Reading
- Fibromyalgia: Causes, Symptoms, and Treatment Options
- Low-Dose Naltrexone (LDN): Uses, Dosing, and Evidence
- PRP Therapy: What the Evidence Says
- Ketamine Therapy: A Complete Guide
- Anti-Aging Supplements Guide
Frequently Asked Questions
What counts as chronic pain?
Chronic pain is pain that persists or recurs for more than three months, according to the IASP classification used in ICD-11. The definition is about more than duration: chronic pain involves measurable changes in how the nerves, spinal cord, and brain process pain signals, so it can continue after the original injury has healed. The CDC estimates that 20.9 percent of US adults had chronic pain in 2021, and 6.9 percent had pain that substantially limited daily life.
Does regenerative therapy like PRP or stem cells work for chronic pain?
PRP has moderate support for knee osteoarthritis, tennis elbow, and plantar fasciitis, while stem cell therapy is still investigational. A 2017 meta-analysis by Dai and colleagues in Arthroscopy found PRP gave better knee pain relief than hyaluronic acid at 12 months. The FDA states that no stem cell or other regenerative medicine product is approved for chronic pain or orthopedic conditions. Both are usually cash pay, so ask clinics for the evidence behind their specific protocol.
Which approaches have the strongest evidence?
Exercise, psychological therapies, and pain neuroscience education have the strongest evidence across chronic pain conditions. CBT has the largest evidence base among psychological treatments, according to a 2020 Cochrane review, and a 2016 JAMA trial found MBSR and CBT both improved function in chronic low back pain more than usual care. Acupuncture outperformed sham treatment for musculoskeletal pain, headache, and osteoarthritis in a 2018 meta-analysis, with effects lasting 12 months.
What are the side effects of common pain medications?
Long-term NSAID use carries risks of gastrointestinal bleeding, cardiovascular events, and kidney damage. Gabapentin and pregabalin can cause drowsiness, dizziness, and weight gain, and there is growing concern about misuse. SNRIs and tricyclic antidepressants can cause nausea, dry mouth, and drowsiness. Long-term opioids carry risks of addiction, overdose, and opioid-induced hyperalgesia, where pain sensitivity increases, and they offer modest long-term benefit at best, according to the 2022 CDC guideline.
How long do interventional treatments last?
Nerve blocks and epidural steroid injections usually relieve pain for weeks to months and can be repeated. Radiofrequency ablation typically lasts 6 to 12 months before the treated nerve regenerates, and the procedure can then be repeated. Spinal cord stimulators are implanted for long-term use after a successful trial period. Ketamine infusion benefit in a 2019 meta-analysis lasted up to about 2 weeks after the infusion, which is why clinics often schedule repeat or booster sessions.
Are these treatments FDA-approved?
Approval varies by treatment. Spinal cord stimulators are FDA approved for chronic neuropathic pain, failed back surgery syndrome, and CRPS, and pregabalin and duloxetine are approved for fibromyalgia. IV ketamine for chronic pain is off label, although esketamine nasal spray is approved for treatment-resistant depression. PRP and prolotherapy are used off label, and the FDA states that stem cell and other regenerative medicine products have not been approved to treat chronic pain or any orthopedic condition.
Sources
- Treede RD, Rief W, Barke A, et al. Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11). Pain. 2019;160(1):19-27. doi:10.1097/j.pain.0000000000001384 ↩
- Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain. 2011;152(3 Suppl):S2-S15. doi:10.1016/j.pain.2010.09.030 ↩
- Finnerup NB, Attal N, Haroutounian S, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015;14(2):162-173. doi:10.1016/S1474-4422(14)70251-0 ↩
- Kosek E, Cohen M, Baron R, et al. Do we need a third mechanistic descriptor for chronic pain states? Pain. 2016;157(7):1382-1386. doi:10.1097/j.pain.0000000000000507 ↩
- Clauw DJ. Fibromyalgia: a clinical review. JAMA. 2014;311(15):1547-1555. doi:10.1001/jama.2014.3266 ↩
- GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries. Lancet. 2018;392(10159):1789-1858. doi:10.1016/S0140-6736(18)32279-7 ↩
- Foster NE, Anema JR, Cherkin D, et al. Prevention and treatment of low back pain: evidence, challenges, and promising directions. Lancet. 2018;391(10137):2368-2383. doi:10.1016/S0140-6736(18)30489-6 ↩
- Harden RN, McCabe CS, Goebel A, et al. Complex regional pain syndrome: practical diagnostic and treatment guidelines, 5th edition. Pain Med. 2022;23(Suppl 1):S1-S53. doi:10.1093/pm/pnac046 ↩
- Dodick DW. Migraine. Lancet. 2018;391(10127):1315-1330. doi:10.1016/S0140-6736(18)30478-1 ↩
- Apkarian AV, Hashmi JA, Baliki MN. Pain and the brain: specificity and plasticity of the brain in clinical chronic pain. Pain. 2011;152(3 Suppl):S49-S64. doi:10.1016/j.pain.2010.11.010 ↩
- Williams ACC, Fisher E, Hearn L, Eccleston C. Psychological therapies for the management of chronic pain (excluding headache) in adults. Cochrane Database Syst Rev. 2020;8:CD007407. doi:10.1002/14651858.CD007407.pub4 ↩
- Enthoven WTM, Roelofs PDDM, Deyo RA, van Tulder MW, Koes BW. Non-steroidal anti-inflammatory drugs for chronic low back pain. Cochrane Database Syst Rev. 2016;2:CD012087. doi:10.1002/14651858.CD012087 ↩
- Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC clinical practice guideline for prescribing opioids for pain, United States, 2022. MMWR Recomm Rep. 2022;71(3):1-95. doi:10.15585/mmwr.rr7103a1 ↩
- Cohen SP, Vase L, Hooten WM. Chronic pain: an update on burden, best practices, and new advances. Lancet. 2021;397(10289):2082-2097. doi:10.1016/S0140-6736(21)00393-7 ↩
- Orhurhu V, Orhurhu MS, Bhatia A, Cohen SP. Ketamine infusions for chronic pain: a systematic review and meta-analysis of randomized controlled trials. Anesth Analg. 2019;129(1):241-254. doi:10.1213/ANE.0000000000004185 ↩
- Lefaucheur JP, Aleman A, Baeken C, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): an update (2014-2018). Clin Neurophysiol. 2020;131(2):474-528. doi:10.1016/j.clinph.2019.11.002 ↩
- Defined Health. Regenerative medicine for musculoskeletal conditions. Defined Health Regenerative Medicine reports. Also: Dai WL, Zhou AG, Zhang H, Zhang J. Efficacy of platelet-rich plasma in the treatment of knee osteoarthritis: a meta-analysis of randomized controlled trials. Arthroscopy. 2017;33(3):659-670.e1. doi:10.1016/j.arthro.2016.09.024 ↩
- Louw A, Zimney K, Puentedura EJ, Diener I. The efficacy of pain neuroscience education on musculoskeletal pain: a systematic review. Physiother Theory Pract. 2016;32(5):332-355. doi:10.1080/09593985.2016.1194646 ↩
- Vickers AJ, Vertosick EA, Lewith G, et al. Acupuncture for chronic pain: update of an individual patient data meta-analysis. J Pain. 2018;19(5):455-474. doi:10.1016/j.jpain.2017.11.005 ↩
- Cherkin DC, Sherman KJ, Balderson BH, et al. Effect of mindfulness-based stress reduction vs cognitive behavioral therapy or usual care on back pain and functional limitations in adults with chronic low back pain: a randomized clinical trial. JAMA. 2016;315(12):1240-1249. doi:10.1001/jama.2016.2323 ↩
- Younger J, Parkitny L, McLain D. The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain. Clin Rheumatol. 2014;33(4):451-459. doi:10.1007/s10067-014-2517-2 ↩
- Kamper SJ, Apeldoorn AT, Chiarotto A, et al. Multidisciplinary biopsychosocial rehabilitation for chronic low back pain: Cochrane systematic review and meta-analysis. BMJ. 2015;350:h444. doi:10.1136/bmj.h444 ↩
- Rikard SM, Strahan AE, Schmit KM, Guy GP Jr. Chronic pain among adults, United States, 2019-2021. MMWR Morb Mortal Wkly Rep. 2023;72(15):379-385. doi:10.15585/mmwr.mm7215a1 ↩
- National Institute for Health and Care Excellence. Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain. NICE guideline NG193. 2021. https://www.nice.org.uk/guidance/ng193 ↩
- US Food and Drug Administration. Important patient and consumer information about regenerative medicine therapies. https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/important-patient-and-consumer-information-about-regenerative-medicine-therapies ↩
- Rabago D, Patterson JJ, Mundt M, et al. Dextrose prolotherapy for knee osteoarthritis: a randomized controlled trial. Ann Fam Med. 2013;11(3):229-237. doi:10.1370/afm.1504 ↩